
亚太神经外科机器人市场预测至 2028 年 - COVID-19 影响和区域分析(按组件 [设备/系统(机器人机器、导航系统、规划器和模拟器等)、配件和服务]、应用 [脊柱(椎板切除术、椎间盘切除术) 、脊柱融合、椎间盘置换、椎间孔切开术等)和颅脑(开颅手术、脑活检、癫痫热消融等)]、手术类型(微创和开放手术)和最终用户(医院、专科诊所等) )
No. of Pages: 182 | Report Code: BMIRE00027514 | Category: Life Sciences
No. of Pages: 182 | Report Code: BMIRE00027514 | Category: Life Sciences
亚太地区神经外科机器人市场预计将从2022年的4.3808亿美元增长到2028年的11.2773亿美元。预计2022年至2028年复合年增长率为17.1% .
产品开发和批准数量不断增加
神经外科机器人市场有许多大大小小的公司。新组件的推出、区域扩张、产品批准和技术进步是公司扩大市场份额的策略之一。随着不断创新和技术进步,神经外科机器人变得比以往任何时候都更安全、更有效,提高了大众的接受度。市场参与者积极参与开发活动,随后监管机构对产品的批准增加,将为未来几年神经外科机器人市场的增长提供利润丰厚的机会。
< span>
亚太地区是神经外科机器人增长最快的区域市场。亚太地区神经外科机器人市场分为中国、日本、印度、韩国、澳大利亚和亚太地区其他地区。由于亚太地区国家的新兴市场参与者、需要外科手术的神经系统疾病的患病率和发病率不断上升、对微创和精准手术的需求不断增加以及先进分子平台的引入,亚太地区在2021年占据了22.49%的市场份额。这些因素预计将在未来几年推动亚太地区神经外科机器人市场的发展。
亚太神经外科机器人市场细分
根据组件类型,亚洲太平洋神经外科机器人市场分为设备/系统、配件和服务。设备/系统部分进一步细分为机器人、导航系统、规划器和系统。模拟器等。预计到 2022 年,配件领域将占据最大的市场份额。亚太地区神经外科机器人市场根据应用分为脊柱和颅脑。脊柱应用进一步细分为脊柱融合术、椎板切除术、椎间盘置换术、椎间盘切除术、椎间孔切开术等。颅骨部分又分为脑活检、癫痫热消融、运动障碍的手术治疗等。到 2022 年,按应用划分,脊柱细分市场预计将占据最大的市场份额。
亚太地区神经外科机器人市场根据手术类型进行细分转变为开放式和微创式。到 2022 年,微创领域预计将占据更大的市场份额。
根据最终用户,亚太神经外科机器人市场分为医院、专业中心等。到 2022 年,医院领域预计将占据最大的市场份额。根据国家/地区,市场分为澳大利亚、中国、印度、日本、韩国和亚太其他地区。预计中国将在 2022 年占据市场主导地位。 Accuray Incorporated; B. 布劳恩梅尔松根股份公司; Brainlab 股份公司;脑纳维生物科技有限公司; Globus 医疗有限公司;美敦力;雷尼绍公司; NuVasive 公司;和 Zimmer Biomet 是该地区神经外科机器人市场的领先公司之一。
Strategic insights for Asia Pacific Neurosurgical Robotics involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 438.08 Million |
Market Size by 2028 | US$ 1,127.73 Million |
Global CAGR (2022 - 2028) | 17.1% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 组件
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia Pacific Neurosurgical Robotics refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia Pacific Neurosurgical Robotics Market is valued at US$ 438.08 Million in 2022, it is projected to reach US$ 1,127.73 Million by 2028.
As per our report Asia Pacific Neurosurgical Robotics Market, the market size is valued at US$ 438.08 Million in 2022, projecting it to reach US$ 1,127.73 Million by 2028. This translates to a CAGR of approximately 17.1% during the forecast period.
The Asia Pacific Neurosurgical Robotics Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Neurosurgical Robotics Market report:
The Asia Pacific Neurosurgical Robotics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Neurosurgical Robotics Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Neurosurgical Robotics Market value chain can benefit from the information contained in a comprehensive market report.